Literature DB >> 17255315

Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis.

Feng Wang1, Shu Shun Li, Ralf Segersvärd, Lisa Strömmer, Karl-Gösta Sundqvist, Jan Holgersson, Johan Permert.   

Abstract

Intratumoral hypoxia and paracrine insulin stimulate the expression of hypoxia inducible factor-1alpha (HIF-1alpha) in pancreatic cancer cells. In the present studies, we investigated whether insulin-induced HIF-1alpha expression is a prerequisite for insulin to induce other trophic effects in MiaPaCa2 human pancreatic cancer cells and whether inhibition of HIF-1alpha expression would decrease tumor glycolysis and improve host energy homeostasis. We found that hypoxia was a prerequisite for induction of HIF-1alpha mRNA expression by insulin in MiaPaCa2 cells. Under hypoxic conditions, insulin stimulated glycolysis, cell proliferation, and the secretion of vascular endothelial growth factor in regular MiaPaCa2 cells but not in a MiaPaCa2 variant (si-MiaPaCa2) that expressed specific short interfering RNA for HIF-1alpha and therefore lacked HIF-1alpha protein. This suggests that HIF-1alpha expression is required for insulin to induce other trophic effects. When si-MiaPaCa2 cells were transplanted into the pancreas of athymic mice, they were less tumorigenic and expressed less hexokinase than regular MiaPaCa2 cells. Body weight gain was attenuated in mice hosting tumors composed of regular MiaPaCa2 but not si-MiaPaCa2 cells. These results suggest that an interaction between insulin and HIF-1alpha helps sustain pancreatic cancer cells and disturbs host energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255315      PMCID: PMC1851851          DOI: 10.2353/ajpath.2007.060489

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Cellular reaction to hypoxia: sensing and responding to an adverse environment.

Authors:  Ioanna Papandreou; Ashley Powell; Ai Lin Lim; Nicholas Denko
Journal:  Mutat Res       Date:  2005-01-06       Impact factor: 2.433

2.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

Authors:  H Zhong; K Chiles; D Feldser; E Laughner; C Hanrahan; M M Georgescu; J W Simons; G L Semenza
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  Effect of low glutamine/glucose on hypoxia-induced elevation of hypoxia-inducible factor-1alpha in human pancreatic cancer MiaPaCa-2 and human prostatic cancer DU-145 cells.

Authors:  Seok Joon Kwon; Yong J Lee
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

4.  Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha.

Authors:  Qi Fang Li; Xiang Rui Wang; Yue Wu Yang; Han Lin
Journal:  Cell Res       Date:  2006-06       Impact factor: 25.617

5.  Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.

Authors:  N Akakura; M Kobayashi; I Horiuchi; A Suzuki; J Wang; J Chen; H Niizeki; M Hosokawa; M Asaka
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.

Authors:  B H Jiang; G Jiang; J Z Zheng; Z Lu; T Hunter; P K Vogt
Journal:  Cell Growth Differ       Date:  2001-07

7.  Pancreatic tumors show high levels of hypoxia.

Authors:  A C Koong; V K Mehta; Q T Le; G A Fisher; D J Terris; J M Brown; A J Bastidas; M Vierra
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

8.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.

Authors:  P J Pollard; J J Brière; N A Alam; J Barwell; E Barclay; N C Wortham; T Hunt; M Mitchell; S Olpin; S J Moat; I P Hargreaves; S J Heales; Y L Chung; J R Griffiths; A Dalgleish; J A McGrath; M J Gleeson; S V Hodgson; R Poulsom; P Rustin; I P M Tomlinson
Journal:  Hum Mol Genet       Date:  2005-06-29       Impact factor: 6.150

9.  Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression.

Authors:  X Z Ding; D M Fehsenfeld; L O Murphy; J Permert; T E Adrian
Journal:  Pancreas       Date:  2000-10       Impact factor: 3.327

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  16 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

Review 2.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  PP56 improves energy homeostasis in a mouse model of pancreatic cancer.

Authors:  Feng Wang; Jörgen Larsson; Margery K Herrington; Johan Permert
Journal:  Tumour Biol       Date:  2010-04-27

4.  Insulin and hypoxia-inducible factor-1 cooperate in pancreatic cancer cells to increase cell viability.

Authors:  Dapeng Zhang; Lihua Cui; Shu Shun Li; Feng Wang
Journal:  Oncol Lett       Date:  2015-06-17       Impact factor: 2.967

5.  Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions.

Authors:  Xiangfei Yuan; Wencong Tian; Yang Hua; Lijuan Hu; Jing Yang; Junmuzi Xie; Jiacai Hu; Feng Wang
Journal:  Exp Ther Med       Date:  2018-10-12       Impact factor: 2.447

6.  Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.

Authors:  Zhiwen Liu; Xiaohui Jia; Yijie Duan; Huijie Xiao; Karl-Gösta Sundqvist; Johan Permert; Feng Wang
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

7.  High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.

Authors:  Andreas-Claudius Hoffmann; Ryutaro Mori; Daniel Vallbohmer; Jan Brabender; Ellen Klein; Uta Drebber; Stephan E Baldus; Janine Cooc; Mizutomo Azuma; Ralf Metzger; Arnulf H Hoelscher; Kathleen D Danenberg; Klaus L Prenzel; Peter V Danenberg
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

8.  Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.

Authors:  Chuangui Chen; Jinjin Sun; Geng Liu; Jianqiu Chen
Journal:  Pathol Oncol Res       Date:  2008-05-29       Impact factor: 3.201

Review 9.  Glucose metabolic phenotype of pancreatic cancer.

Authors:  Anthony K C Chan; Jason I E Bruce; Ajith K Siriwardena
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 10.  Critical protein GAPDH and its regulatory mechanisms in cancer cells.

Authors:  Jin-Ying Zhang; Fan Zhang; Chao-Qun Hong; Armando E Giuliano; Xiao-Jiang Cui; Guang-Ji Zhou; Guo-Jun Zhang; Yu-Kun Cui
Journal:  Cancer Biol Med       Date:  2015-03       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.